Key result
Statins demonstrate cardioprotective effects against ischaemia/reperfusion injury, an effect that appears to be a class-effect mediated by the activation and up-regulation of eNOS.
Why the study?
Do statins provide cardioprotective effects against ischaemia/reperfusion injury beyond lipid lowering?
Do statins provide cardioprotective effects against ischaemia/reperfusion injury beyond lipid lowering?
Statins may offer direct cardioprotection against ischemia/reperfusion injury via eNOS upregulation, independent of their lipid-lowering effects.
Answers are grounded in this paper and cite their sources.
Suggests statins may confer eNOS-mediated protection against ischemia/reperfusion injury beyond lipid lowering; hypothesis-generating pending randomized trials.
Many large randomized clinical trials have demonstrated that statins are effective in terms of prevention of cardiovascular events. It has been presumed that these beneficial effects could be due to not only improved plasma lipid profiles but also to the direct actions on the vascular wall. In addition to the direct vascular protective effects, several lines of experimental evidence have been accumulated that statins have also cardioprotective effects against ischaemia/reperfusion injury. This effect appears to be a class-effect and activation and up-regulation of eNOS by statins play an important role.
No takes yet. Share an insight, caveat, or question.
Eto et al. (2004) conducted a review in Cardiovascular events. Statins was evaluated. Statins demonstrate cardioprotective effects against ischaemia/reperfusion injury, an effect that appears to be a class-effect mediated by the activation and up-regulation of eNOS.
Synapse has enriched 10 related papers. Consider them for comparative context: